ID: ALA538744

Max Phase: Preclinical

Molecular Formula: C10H13ClFNO

Molecular Weight: 181.21

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccccc1/C(=C\F)CN.Cl

Standard InChI:  InChI=1S/C10H12FNO.ClH/c1-13-10-5-3-2-4-9(10)8(6-11)7-12;/h2-6H,7,12H2,1H3;1H/b8-6-;

Standard InChI Key:  MGEPKEJABFERDK-PHZXCRFESA-N

Associated Targets(non-human)

Monoamine oxidase 439 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 181.21Molecular Weight (Monoisotopic): 181.0903AlogP: 1.96#Rotatable Bonds: 3
Polar Surface Area: 35.25Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.03CX LogP: 1.32CX LogD: -0.30
Aromatic Rings: 1Heavy Atoms: 13QED Weighted: 0.77Np Likeness Score: -0.37

References

1. McDonald IA, Lacoste JM, Bey P, Palfreyman MG, Zreika M..  (1985)  Enzyme-activated irreversible inhibitors of monoamine oxidase: phenylallylamine structure-activity relationships.,  28  (2): [PMID:3968682] [10.1021/jm00380a007]

Source